A 51-year-old male with three weeks of increasing back pain, sciatalgia, and recent fever spike searched medical attention. Clinical examination highlights positive Lasègue and tender right fossa. Laboratory testing returns high C reactive protein and leucocytosis.

Pelvic MRI reveals an ill-defined large enhancing overall low ADC mass (Figure [1D](#F1){ref-type="fig"}, larger ROI) with smaller non-enhancing pockets (arrows in Figure [1B](#F1){ref-type="fig"}, [C](#F1){ref-type="fig"}) with very low ADC:566 (Figure [1D](#F1){ref-type="fig"}, small ROI) and high signal on b-800 images (Figure [1E](#F1){ref-type="fig"}, arrows). They are hard to see on low b-value images (Figure [1F](#F1){ref-type="fig"}, arrows), but they stand out on Maximum Intensity Projection b-800 image (Figure [1A](#F1){ref-type="fig"}). Note the aggressive crossing of fat planes and invasion of bladder and piriform, iliac and obturator muscle. There are no ascites nor enlarged lymph nodes. Differential diagnosis included malignancy versus pseudotumor or mass-like infection. Chest CT (not shown) demonstrates nodules in both lungs and left lower lobe patchy air-space consolidation, which might suggest fungal or atypical bacterial infection, e.g. Nocardia or Actinomycosis rather than metastatic disease.

![MRI at initial presentation with T1 fatsat images post gado **(B, C)** and DWI images **(A, D, E, F)**.](jbsr-102-1-1387-g1){#F1}

Frozen sections on surgical tissue samples (anterior to the right anterior iliac crest) reveals connective tissue, fat, muscle, and inflamed tissue without malignancy. Formalin fixed and paraffin embedded HE-stained sections (Figure [2](#F2){ref-type="fig"}) shows striking deposition of star-like eosinophilic material round blue filamentous bacteria (Splendore-Hoeppli phenomenon), which is pathognomonic for Actinomyces.

![Formalin fixed and paraffin embedded HE-stained section.](jbsr-102-1-1387-g2){#F2}

The match of radiology and pathology findings is consistent with pseudotumoral Actinomycosis. Treatment with Amoxicillin/clavulanic acid results in pain relief and clear clinical and biochemical improvement. After six weeks of treatment there is marked volume loss of the mass and better delineation of bladder and psoas muscle (Figure [3](#F3){ref-type="fig"}; pre- vs post-treatment MRI). ADC values in the residual mass are higher after treatment (ROI measurement Figure [3D](#F3){ref-type="fig"} versus Figure [3A](#F3){ref-type="fig"}). The pus containing pocket (Figure [3A](#F3){ref-type="fig"}, [B](#F3){ref-type="fig"} arrow) has disappeared (Figure [3E](#F3){ref-type="fig"}) after treatment.

![DWI images at initial presentation **(A, B, C)** and after six weeks of antibiotics **(D, E, F)**.](jbsr-102-1-1387-g3){#F3}

Actinomycosis is a rare, chronic, destructive, invasive gram-positive bacterial infection. It has been reported as odontogenic, in the head and neck (mandibular osteomyelitis) and thoracic region. Abdominal, pelvic actinomycosis is even more rare and mainly found in immunocompromised patients. In women, IUCD-associated pelvic actinomycosis has been reported. Our patient, however, had no medical history except for orchitis treated three months ago. Without clinical tell-tale signs, e.g. cutaneous sinus tracts, diagnosing actinomycosis can be a challenge. Aggressive pseudo-tumor presentation and hematogenous spread to the central nervous system and lungs is possible \[[@B1]\].

Suggesting the diagnosis of actinomycosis early is vital in patient management: timely antibiotics do cure the patient. Besides clinical and laboratory findings of inflammation, imaging features can provide us with a few hints. Actinomycosis is highly aggressive, infiltrating tissues, crossing fatplanes, and can invade muscles, organs, bones, and joints. Small non-enhancing microabcesses with striking low ADC might be a clue to look for. During treatment, measuring ADC values allows for non-invasive monitoring of pus content in the micro-abcesses.
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